The global enteric disease testing market is projected to grow from $4.08 billion in 2025 to $5.86 billion by 2035, at a CAGR of 3.7%. Growth is fueled by rising foodborne and waterborne diseases, demand for rapid pathogen detection, and adoption of multiplex molecular diagnostics and lab automation. North America leads the market, with the U.S. expected to reach $1.53 billion by 2035, while Asia-Pacific is the fastest-growing region due to urbanization and increased healthcare investment. Advances in molecular testing and public health surveillance are key drivers of this expansion.
Danaher Corporation announced its second quarter 2026 earnings conference call will be held on July 21 at 8:00 a.m. ET. The company will discuss its financial results and future outlook during the call, which will be webcast live on its investor webs...
The global ovarian cancer diagnostics market is projected to grow from $4.92 billion in 2025 to $8.08 billion by 2035, at a CAGR of 5.06%. Growth is fueled by rising ovarian cancer cases, increased adoption of AI-powered imaging, biomarker testing, a...
The global automated liquid handling systems market was valued at $2.7 billion in 2025 and is projected to grow to $6.9 billion by 2035, with a compound annual growth rate (CAGR) of 9.8%. This growth is driven by increasing pharmaceutical and biotech...
